Alexandra Balcom, Chief Financial Officer at Nuvalent, Inc. (NUVL), sold 3,366 shares at $85.57 ($288K) on 2025-10-15, disclosed to the SEC on 2025-10-17.
Scheduled sale ($288k) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $85.57 | 1,683 | $144K | 50.0% |
| 2 | $85.57 | 1,683 | $144K | 50.0% |
| Total | $85.57 avg | 3,366 | $288K | 100% |
| Filing → |
| NUVL | SELL | 2026-05-05 | $1.1M | — | Filing → |
| NUVL | SELL | 2026-04-03 | $1.2M | — | Filing → |
| NUVL | SELL | 2026-03-26 | $2.5M | — | Filing → |